NAFCILLIN SODIUM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nafcillin Sodium, and what generic alternatives are available?
Nafcillin Sodium is a drug marketed by Antibiotice, Apothecon, Eugia Pharma Speclts, Fresenius, Istituto Bio Ita Spa, Onesource Specialty, Sagent Pharms, Sandoz, and Watson Labs Inc. and is included in fifteen NDAs.
The generic ingredient in NAFCILLIN SODIUM is nafcillin sodium. There are eleven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the nafcillin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nafcillin Sodium
A generic version of NAFCILLIN SODIUM was approved as nafcillin sodium by ISTITUTO BIO ITA SPA on April 20th, 2011.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for NAFCILLIN SODIUM?
- What are the global sales for NAFCILLIN SODIUM?
- What is Average Wholesale Price for NAFCILLIN SODIUM?
Summary for NAFCILLIN SODIUM
| US Patents: | 0 |
| Applicants: | 9 |
| NDAs: | 15 |
| Finished Product Suppliers / Packagers: | 10 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 1 |
| Patent Applications: | 1,187 |
| DailyMed Link: | NAFCILLIN SODIUM at DailyMed |
Recent Clinical Trials for NAFCILLIN SODIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Federal University of São Paulo | Phase 4 |
| Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
Pharmacology for NAFCILLIN SODIUM
| Drug Class | Penicillin-class Antibacterial |
Medical Subject Heading (MeSH) Categories for NAFCILLIN SODIUM
Anatomical Therapeutic Chemical (ATC) Classes for NAFCILLIN SODIUM
US Patents and Regulatory Information for NAFCILLIN SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs Inc | NAFCILLIN SODIUM | nafcillin sodium | INJECTABLE;INJECTION | 062844-001 | Oct 26, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Watson Labs Inc | NAFCILLIN SODIUM | nafcillin sodium | INJECTABLE;INJECTION | 062844-003 | Oct 26, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Watson Labs Inc | NAFCILLIN SODIUM | nafcillin sodium | INJECTABLE;INJECTION | 062844-004 | Oct 26, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Antibiotice | NAFCILLIN SODIUM | nafcillin sodium | INJECTABLE;INJECTION | 090560-001 | Oct 3, 2011 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Sagent Pharms | NAFCILLIN SODIUM | nafcillin sodium | INJECTABLE;INJECTION | 090582-001 | Aug 24, 2012 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
